indazoles has been researched along with Cystadenocarcinoma, Serous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, S; Khor, XY; Yiannakis, D | 1 |
| Longo, DL | 1 |
2 other study(ies) available for indazoles and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases.
Topics: Aged; Brain Neoplasms; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Indazoles; Maintenance Chemotherapy; Neoplasm Grading; Ovarian Neoplasms; Piperidines; Treatment Outcome | 2019 |
Personalized Medicine for Primary Treatment of Serous Ovarian Cancer.
Topics: Cystadenocarcinoma, Serous; Female; Humans; Indazoles; Ovarian Neoplasms; Piperidines; Precision Medicine | 2019 |